DEUTSCHE BANK AG\
BankPosition in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in LXRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$594,066
+$550,645 QoQ
Shares Held
247,528
+162.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 148 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. LXRX ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in LXRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $594,066 | 247,528 | Shares | Defined | 2026-08-07 | |
| 2025-03-31 | $43,421 | 94,394 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $233,587 | 315,659 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $103,686 | 66,043 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $53,574 | 31,890 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $92,968 | 38,737 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $61,641 | 40,289 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $43,914 | 40,289 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $92,261 | 40,289 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $127,878 | 52,625 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $69,993 | 36,646 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $86,615 | 36,090 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $61,551 | 33,092 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $79,199 | 37,895 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $167,098 | 42,411 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $193,616 | 40,253 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $763,229 | 166,281 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $516,547 | 87,998 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $523,860 | 153,176 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $891,834 | 619,330 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $40,424 | 20,212 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $27,558 | 14,133 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||